Janice Stipp
Analyst · CJS Securities. Your line is open
Thank you, Bruce, and good morning, everyone. I’m very pleased to be part of the Rogers team and the core to interacting with all of you in the months and years to come. Before I review the results for Q4 2015, I’d like to briefly touch upon my priorities and objectives, as we move forward. If you turn to Slide 14, I’ve outlined five key areas that will be a focus for the finance, organization, and supporting the roadmap Bruce touched upon earlier. As a market-driven organization, we’ll partner with sales and technology to continue to look for areas to increase revenue by strategically investing in technology that will drive upon the goals of margin expansion, customer and geographic diversification, and long-term growth outlook of the markets we participate in. Optimizing our cost structure and focusing on increasing cash flow, we will – with the key as we partner with operations, the pricing and other departments to support Rogers operational excellence initiative. At any time, but especially during times of global economic uncertainty as we have today, it is important to benchmark the global competitiveness of the company’s cost structure and adjust as necessary to maximize user working capital and deploy a balanced discipline and flexible approach enchasing our capital structure. Lastly, our synergistic approach to M&A will allow Rogers to continue to identify and leverage acquisition opportunities that will deliver on established target similar to the benefits obtained we think with our own acquisition. These top priorities are all focused on creating value for our shareholders and we will continue to prioritize those initiatives that meet that objective. Before we move on to Slide 15, I wanted to highlight that we will be introducing some new metrics during our call today that will establish on the basis of how we communicate results in the future. In certain slides, the consolidated results presented will exclude restructuring, non-cash stock-based compensation, amortization, and other discrete special charges by other slides are presented using the historical Rogers’ methodology. Each financial metric has been footnoted as calculation and the reconciliation between GAAP and non-GAAP is included at the back of this presentation. The new metrics are aimed at addressing the continuing core operations of Rogers on a comparative basis, I’ll first begin by covering our fourth quarter results followed by a brief overview of our full-year 2015 performance, and then lastly, I’ll discuss our Q1 2016 guidance. Now, let’s take a look at our Q4 2015 financial results beginning with Slide 15. On this slide, we’ll be reviewing the results that Rogers has historically communicated back. In the fourth quarter of 2015, net revenues was $152.9 million, was up 3.5% compared to the fourth quarter of 2014. Adjusted operating margin was down 380 basis points, primarily due to low organic revenue and higher investment in R&D, both of which are partially offset with lower incentive compensation expense and other SG&A cost saving initiatives. The lower margin drove the overall reduction in non-GAAP earnings per share to $0.69 in the fourth quarter of 2015 compared to $0.91 in the fourth quarter of 2014. Moving to Slide 16, we – new metrics I addressed earlier. One such metric is EBITDA defined as earnings before interest, taxes, depreciation and amortization adjusted for restructuring non-cash stock-based compensation and other discrete special charges. Management believes this measurement assist in comparing our operating performance over various following periods on a consistent basis because of the renewals of our operating results, the impact of items that management’s opinion do not reflect core operating performance. In addition, we believe EBITDA is useful because of besides analysts, investors and others the same information that we use internally for the purpose of assessing our core operating performance. However, this financial measure should not be considered as a better measurement in financial measurement calculated in accordance with GAAP. Lastly, I’ll caution that other companies that calculate EBITDA differently, therefore, our EBITDA may not be comparable to other companies.
%: EBITDA was down 270 basis points for primarily the same reason. The lower operating margin led to the overall reduction in adjusted earnings per share to $0.88 in the fourth quarter of 2015 compared to $1.04 in the fourth quarter of 2014. Slide 17 provides greater detail on revenue in the quarter. As Bruce stated, there were significant market headwinds resulting in delays in capital investments and key infrastructure projects that impacted our organic revenue this quarter, which contribute to a deterioration of a 11% on a currency neutral basis. Our organic revenue in each of our business segments was unfavorable resulting in $16.2 million of revenue deterioration in Q4 2015. ACS segment results were favorably impacted by strong growth in high-frequency circuit materials used in automotive Advanced Driver Assistance Systems and aerospace and defense applications. However, weaker demand in the 4G LTE base station supply chain, primarily in China led to an overall decline in ACS segment revenues for the quarter. While our EMS segment results were favorably impacted by increases in consumer automotive applications, both continued decline in certain portable electronic applications led to overall reduced revenue in this segment. Lastly, results for our PES segment were favorably impacted by increased demand on electric vehicles and certain renewable energy applications, although lower demand in mass transit applications resulted in lower organic revenue for this segment. Fluctuations in currency exchange was unfavorably impacted net revenue by 3.5%. The acquisition of Arlon contributed $26.6 million, or 18% of our revenue in the quarter. Looking at our adjusted operating income on Slide 18, fourth quarter results declined 300 basis points, or $3.7 million compared to the fourth quarter of 2014. Gross margin declined 530 basis points, primarily due to low organic volume mix, volume related pricing absorption and warranty expense. Commercial expenses were lower by 230 basis points due to lower incentive compensation accruals and cost initiatives, partially offset by higher investment in R&D. First, take a look at our segment financials on Slide 19. Since Bruce, have already covered segment revenue in some detail, I will focus on operating income adjusted here for the restructuring and other non-discreet special charges only. ACS operating income was $10 million, down $0.1 million from 2014 Q4 or 190 basis points as a percent of revenue. This decrease was primarily due to organic revenue and unfavorable absorption partially offset by the acquisition operating income. EMS operating income was $4.3 million, down $1.9 million from Q4 2014 or 440 basis points, as a percent of revenue. This decrease was a result of organic revenue as well as unfavorable mix and absorption, partially offset by the acquisitions operating income. PES operating income was $0.8 million, down $2.7 million. As a percent of revenue, the decrease was 620 basis points. This decrease is primarily due to low organic revenue, volume rebate, or an expense in unfavorable absorption. Moving to Slide 20, you’ll see the waterfall chart were due to changes in adjusted earnings per share from Q4 2014 to Q4 2015. The $1.4 down from adjusted earnings per share last year is reduced by $0.06 of intangible amortization and $0.07 of non-cash stock-based compensation, resulting in $0.91 for Q4 2014 earnings per share less special adjustment. This was reduced by $0.68 due to the lower volume, volume-related pricing, unfavorable absorption, and mix. Reduced commercial expenses contributed $0.25 of earnings per share improvement, primarily due to lower incentive compensation accruals in 2015, which is being partially offset by $0.05 of earnings per share deterioration due to increased investment in R&D. The Arlon acquisition added $0.26 to earnings per share, which resulted in $0.69 of Q4 2015 earnings per share less special adjustments, which exceeded the guidance estimate of $0.53 to $0.63 per share. As I mentioned earlier, Rogers will be introducing some new metrics. The management teams believe to better understand the core operational business performance if added back intangible amortization and non-cash stock-based compensation to calculate an adjusted earnings per share metrics. As you can see in this chart, starting with the $0.69 of Q4 2015 earnings per share less special adjustment adding a $0.11 for intangible amortization and $0.8 for non-cash stock-based compensation, the core business performance was $0.88 of adjusted earnings per share. Now, let’s take a look at the full-year 2015 financial results beginning on Slide 21. This slide illustrates the results that Rogers have historically communicated back. Rogers delivered all-time record revenue of $641.1 million, an increase of 5% over fiscal year 2014. Organic sales were down 6.9% on a currency neutral basis and fluctuation in currency exchange rates will result by 4.5%. The Arlon acquisition increased revenue by 16.4%. Adjusted operating margin was down 90 basis points from 14.6% in 2014 to 13.7% in 2015. The main contributing factors are accretive results of acquired business partially offset by purchase accounting, as well as SG&A savings primarily due to lower incentive compensation partially offset by organic volume and mix and higher investment in R&D. Non-GAAP earnings per share was $3.08 in 2015, which is down 9.7% over $3.41 in 2014. Turning to Slide 22, you’ll see the full-year 2015 results with the new metric. Adjusted operating margin was up 10 basis points and 16.8% for the full-year 2014 to 16.9% for the full-year 2015. The improvement from the historical non-GAAP operating income of 100 basis points is driven by 70 basis points from intangible amortization and 30 basis points from non-cash stock-based compensation. EBITDA is also up 10 basis points from 20.6% for the full-year of 2014 to 20.7% in the full-year 2015. This is driven by the explanations already noted. Adjusted earnings per share were $3.84 in 2015, which was down 2.3% over the $3.93 in 2014. The primary reason for the decline is due to increased interest expense and tax rate associated with adjusted earnings per share. On Slide 23, you’ll see the full-year segment financial. ACS revenue increased 11.1% in 2015. Organic revenue declined a 11.4%. Currency fluctuations decreased results by 1.3% and the acquisition added 23.8%, as compared to the prior year. ACS operating income for 2015 increased by $3.5 million that was lower by 70 basis points. Our organic revenue was partially offset by the addition of the operating income from the acquisition, favorable results from the continued efforts target at manufacturing efficiency and improvement and favorable inventory absorption. Organic revenue in our EMS segment declined 7.9%, while currency fluctuations decreased results by 1.8%, and the acquisition added 13.8% of growth as compared to the prior year. EMS operating income declined 180 basis points, primarily due to the low organic revenue and mix, partially upset by the addition of operating income and the acquisition of productivity improvement. PES organic revenue was basically flat compared to 2014, despite an unfavorable currency impact of 12% when compared to the prior year. PES operating income declined a 110 basis points primarily due to organic revenue and mix, unfavorable foreign currency exchange impact. [Volume for entry-based] [ph] warranty expense partially offset by improvements in yield and productivity. Turning to Slide 24, you can see we added here with a strong cash position of $204.6 million. Rogers generated $73.9 million of cash flow from operation and repurchased 40 million of shares during the last half of the year. We also made progress on executing on our growth strategy by utilizing $125 million of borrowings on our bank credit facility to help fund the successful acquisition of Arlon. During the year, we also invested $24.8 million in capital expenditures that help strengthen our competitive position, as well as we exited a non-core product line. Slide 25 describes our capital allocation over the last three years. Cap expenditures have been roughly 30% of the operating cash flow, another 17% towards share repurchase and 14% toward net acquisition activity. We’ll remain flexible on our operating cash flow to support a strong balance sheet in the phase of continued economic uncertainty, as well as any opportunistic acquisition. We will stay focus on value enhancing initiative and assets intent to deploy operating cash flow in a balanced and disciplined manner towards accretive strategic acquisitions, capital investments, and continued share repurchases. Taking a look at our Q1 2016 guidance on Slide 26, revenues are estimated in the range of $148 million to $156 million and net earnings to be in the range of $0.51 to $0.61 per diluted share from $0.72 to $0.82 on an adjusted earnings per share basis. At the midpoint, our Q1 2016 revenue guidance represented organic revenue decline of 2% over Q1 2015 and another 3% unfavorable currency fluctuation and additional 3% resulting from the Q4 2015 divesture of non-core product line. Guidance for earning per share has a midpoint $0.56 per diluted share, which reflect the reduction of $0.37 per diluted share compared to earnings per share in Q1 2015. This decrease is due to several factors, including $0.32 related to lower revenue and expected higher R&D investments of $0.03. Given the recent developments in our global markets, I’d like to take a moment to compare the Q1 2015 guidance estimate to the Q4 2015 results. Compared to Q4 2015, we expect first quarter revenues to remain relatively flat, because even though we anticipate a slight increase in the organic business that increase will be offset by the divesture of the non-core product line. We also expect a decline in earnings per share of $0.13 per diluted share at the midpoint compared to Q4 of 2015 non-GAAP earnings per share less special charges of $0.69 per diluted share. This decrease was due to higher forecasted estimate primarily due to incentive compensation expense, as well expand higher tax rates in Q1 2015, due to the absence of the release of certain tax provisions that occurred in the fourth quarter of 2015. The negative impact of these items expect to be partially offset by the higher organic revenue. In summary, we believe we’re well-positioned to deliver shareholder value in 2016 and beyond. We continue to aggressively optimize our cost structure in the phase of economic uncertainty as [indiscernible] generally remaining strategically positioned to capitalize on growth in our megatrend markets pursuing accretive acquisitions and continued to invest in technology and in innovation to adjust our customer’s need. I will now turn the call back over to Bruce. Bruce?